KDM6A and Miyoshi myopathy: Recently, the tumour-suppressive H3K27 demethylase KDM6A was suggested to guide increased H3K27ac at enhancers, whereas its frequent loss in MM could be attributed to increase of H3K27me3 levels and silencing of immune response genes37.